Heron Therapeutics Inc (NASDAQ:HRTX)

32.65
Delayed Data
As of May 18
 -0.70 / -2.10%
Today’s Change
12.70
Today|||52-Week Range
34.00
+80.39%
Year-to-Date
No recent news for Heron Therapeutics Inc.

Today’s Trading

Previous close33.35
Today’s open33.40
Day’s range32.15 - 33.70
Volume888,769
Average volume (3 months)1,225,803
Market cap$2.3B
Data as of 4:00pm ET, 05/18/2018

Growth & Valuation

Earnings growth (last year)+20.05%
Earnings growth (this year)+32.29%
Earnings growth (next 5 years)+18.90%
Revenue growth (last year)+2,305.55%
P/E ratioNM
Price/Sales31.79
Price/Book15.99

Competitors

 Today’s
change
Today’s
% change
ZIOPZIOPHARM Oncology In...+0.02+0.45%
ACORAcorda Therapeutics ...-0.45-1.86%
ATNXAthenex Inc0.000.00%
BYSIBeyondspring Inc-0.23-0.83%
Data as of 4:00pm ET, 05/18/2018

Financials

Next reporting dateAugust 6, 2018
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$30.8M
Annual profit (last year)-$197.5M
Net profit margin-641.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
San Diego, California

Forecasts